{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:25:32Z","timestamp":1794000332705,"version":"4.8.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Youth Fund of the National Natural Science Foundation of China","award":["82200232"],"award-info":[{"award-number":["82200232"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00277-024-05716-w","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T02:01:50Z","timestamp":1712887310000},"page":"2445-2454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Upfront allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia\/lymphoma in first complete remission: a single-center study"],"prefix":"10.1007","volume":"103","author":[{"given":"Zhenyang","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangshu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunji","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,12]]},"reference":[{"key":"5716_CR1","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1182\/blood-2009-08-231217","volume":"114","author":"DI Marks","year":"2009","unstructured":"Marks DI, Paietta EM, Moorman AV et al (2009) T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII\/ECOG 2993). Blood 114:5136\u20135145","journal-title":"Blood"},{"key":"5716_CR2","first-page":"266","volume":"15","author":"M Yilmaz","year":"2017","unstructured":"Yilmaz M, Kantarjian H, Jabbour E (2017) Treatment of acute lymphoblastic leukemia in older adults: now and the future. Clin Adv Hematol Oncol 15:266\u2013274","journal-title":"Clin Adv Hematol Oncol"},{"key":"5716_CR3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","volume":"27","author":"F Huguet","year":"2009","unstructured":"Huguet F, Leguay T, Raffoux E et al (2009) Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J Clin Oncol 27:911\u2013918","journal-title":"J Clin Oncol"},{"key":"5716_CR4","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1200\/JCO.2007.13.7265","volume":"26","author":"JM Ribera","year":"2008","unstructured":"Ribera JM, Oriol A, Sanz MA et al (2008) Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Espanol De Tratamiento en Hematologia pediatric-based protocol ALL-96. J Clin Oncol 26:1843\u20131849","journal-title":"J Clin Oncol"},{"key":"5716_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11864-020-00757-5","volume":"21","author":"AA Patel","year":"2020","unstructured":"Patel AA, Thomas J, Rojek AE, Stock W (2020) Biology and Treatment paradigms in T Cell Acute Lymphoblastic Leukemia in older adolescents and adults. Curr Treat Options Oncol 21:57","journal-title":"Curr Treat Options Oncol"},{"key":"5716_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/bjh.16207","volume":"188","author":"H Rafei","year":"2020","unstructured":"Rafei H, Kantarjian HM, Jabbour EJ (2020) Targeted therapy paves the way for the cure of acute lymphoblastic leukaemia. Br J Haematol 188:207\u2013223","journal-title":"Br J Haematol"},{"key":"5716_CR7","first-page":"85","volume":"1","author":"E Maffini","year":"2019","unstructured":"Maffini E, Saraceni F, Lanza F (2019) Treatment of adult patients with Relapsed\/Refractory B-Cell Philadelphia-negative Acute Lymphoblastic Leukemia. Clin Hematol Int 1:85\u201393","journal-title":"Clin Hematol Int"},{"key":"5716_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13045-021-01159-2","volume":"14","author":"XH Zhang","year":"2021","unstructured":"Zhang XH, Chen J, Han MZ et al (2021) The consensus from the Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. J Hematol Oncol 14:145","journal-title":"J Hematol Oncol"},{"key":"5716_CR9","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.6004\/jnccn.2021.0042","volume":"19","author":"PA Brown","year":"2021","unstructured":"Brown PA, Shah B, Advani A et al (2021) Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice guidelines in Oncology. J Natl Compr Canc Netw 19:1079\u20131109","journal-title":"J Natl Compr Canc Netw"},{"key":"5716_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","volume":"10","author":"E Coustan-Smith","year":"2009","unstructured":"Coustan-Smith E, Mullighan CG, Onciu M et al (2009) Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol 10:147\u2013156","journal-title":"Lancet Oncol"},{"key":"5716_CR11","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00277-018-3559-3","volume":"98","author":"Z Gu","year":"2019","unstructured":"Gu Z, Wang L, Wang Q et al (2019) Outcomes of myeloablative peripheral blood stem cell transplantation for non-complete remission patients with relapsed\/refractory peripheral T cell lymphomas. Ann Hematol 98:1237\u20131247","journal-title":"Ann Hematol"},{"key":"5716_CR12","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/cncr.34091","volume":"128","author":"Z Gu","year":"2022","unstructured":"Gu Z, Xiong Q, Wang L et al (2022) The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation. Cancer 128:1402\u20131410","journal-title":"Cancer"},{"key":"5716_CR13","unstructured":"Przepiorka D, Weisdorf D, Martin P et al (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. ; 15: 825\u2013828"},{"key":"5716_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M et al (2015) National Institutes of Health Consensus Development Project on Criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and Staging Working Group report. Biol Blood Marrow Transpl 21:389\u2013401e381","journal-title":"Biol Blood Marrow Transpl"},{"key":"5716_CR15","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.bbmt.2012.07.011","volume":"18","author":"M Bakr","year":"2012","unstructured":"Bakr M, Rasheed W, Mohamed SY et al (2012) Allogeneic hematopoietic stem cell transplantation in adolescent and adult patients with high-risk T cell acute lymphoblastic leukemia. Biol Blood Marrow Transpl 18:1897\u20131904","journal-title":"Biol Blood Marrow Transpl"},{"key":"5716_CR16","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.bbmt.2017.04.003","volume":"23","author":"BK Hamilton","year":"2017","unstructured":"Hamilton BK, Rybicki L, Abounader D et al (2017) Allogeneic hematopoietic cell transplantation for adult T cell Acute Lymphoblastic Leukemia. Biol Blood Marrow Transpl 23:1117\u20131121","journal-title":"Biol Blood Marrow Transpl"},{"key":"5716_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/bmt.2015.278","volume":"51","author":"X Cahu","year":"2016","unstructured":"Cahu X, Labopin M, Giebel S et al (2016) Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT. Bone Marrow Transpl 51:351\u2013357","journal-title":"Bone Marrow Transpl"},{"key":"5716_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/bmt.2016.194","volume":"52","author":"JE Brammer","year":"2017","unstructured":"Brammer JE, Saliba RM, Jorgensen JL et al (2017) Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes. Bone Marrow Transpl 52:20\u201327","journal-title":"Bone Marrow Transpl"},{"key":"5716_CR19","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.bbmt.2020.01.003","volume":"26","author":"A Bazarbachi","year":"2020","unstructured":"Bazarbachi A, Labopin M, Angelucci E et al (2020) Haploidentical transplantation with Post-transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: a report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party. Biol Blood Marrow Transpl 26:936\u2013942","journal-title":"Biol Blood Marrow Transpl"},{"key":"5716_CR20","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1038\/s41409-022-01796-2","volume":"57","author":"HZ Qi","year":"2022","unstructured":"Qi HZ, Xu J, Yang QQ et al (2022) Effect of pediatric- versus adult-type chemotherapy regimens on outcomes of allogeneic hematopoietic stem cell transplants for adult T-cell acute lymphoblastic leukemia in first complete remission. Bone Marrow Transpl 57:1704\u20131711","journal-title":"Bone Marrow Transpl"},{"key":"5716_CR21","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1200\/JCO.2004.10.050","volume":"22","author":"X Thomas","year":"2004","unstructured":"Thomas X, Boiron JM, Huguet F et al (2004) Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 22:4075\u20134086","journal-title":"J Clin Oncol"},{"key":"5716_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","volume":"27","author":"K Tsukasaki","year":"2009","unstructured":"Tsukasaki K, Hermine O, Bazarbachi A et al (2009) Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 27:453\u2013459","journal-title":"J Clin Oncol"},{"key":"5716_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1182\/hematology.2022000337","volume":"2022","author":"KM O\u2019Dwyer","year":"2022","unstructured":"O\u2019Dwyer KM (2022) Optimal approach to T-cell ALL. Hematol Am Soc Hematol Educ Program 2022:197\u2013205","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"5716_CR24","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1182\/blood-2014-01-547695","volume":"123","author":"K Beldjord","year":"2014","unstructured":"Beldjord K, Chevret S, Asnafi V et al (2014) Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia. Blood 123:3739\u20133749","journal-title":"Blood"},{"key":"5716_CR25","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1182\/blood-2011-09-377713","volume":"120","author":"N Gokbuget","year":"2012","unstructured":"Gokbuget N, Kneba M, Raff T et al (2012) Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies. Blood 120:1868\u20131876","journal-title":"Blood"},{"key":"5716_CR26","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1200\/JCO.2016.71.8585","volume":"35","author":"J Bond","year":"2017","unstructured":"Bond J, Graux C, Lhermitte L et al (2017) Early response-based therapy stratification improves survival in adult early thymic precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study. J Clin Oncol 35:2683\u20132691","journal-title":"J Clin Oncol"},{"key":"5716_CR27","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1182\/blood-2011-03-338707","volume":"118","author":"M Schrappe","year":"2011","unstructured":"Schrappe M, Valsecchi MG, Bartram CR et al (2011) Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood 118:2077\u20132084","journal-title":"Blood"},{"key":"5716_CR28","doi-asserted-by":"publisher","first-page":"e170580","DOI":"10.1001\/jamaoncol.2017.0580","volume":"3","author":"DA Berry","year":"2017","unstructured":"Berry DA, Zhou S, Higley H et al (2017) Association of minimal residual Disease with Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: a Meta-analysis. JAMA Oncol 3:e170580","journal-title":"JAMA Oncol"},{"key":"5716_CR29","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1182\/blood-2014-09-599894","volume":"125","author":"N Dhedin","year":"2015","unstructured":"Dhedin N, Huynh A, Maury S et al (2015) Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia. Blood 125:2486\u20132496 quiz 2586","journal-title":"Blood"},{"key":"5716_CR30","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","volume":"109","author":"AK Fielding","year":"2007","unstructured":"Fielding AK, Richards SM, Chopra R et al (2007) Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study. Blood 109:944\u2013950","journal-title":"Blood"},{"key":"5716_CR31","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41409-019-0702-2","volume":"55","author":"AH Bazarbachi","year":"2020","unstructured":"Bazarbachi AH, Al Hamed R, Labopin M et al (2020) Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party. Bone Marrow Transpl 55:595\u2013602","journal-title":"Bone Marrow Transpl"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05716-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05716-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05716-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T16:05:20Z","timestamp":1720109120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05716-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["5716"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05716-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,12]]},"assertion":[{"value":"13 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declared that they had no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The Medical Ethics Committee of PLA General Hospital reviewed and approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors agree that this manuscript can be published in Annals of Hematology.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}